Amneal Pharmaceuticals (AMRX) Tax Rate (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted Tax Rate of 1.94% for Q2 2026, down 28.58% on a QoQ basis from 2.71% in Q1 2026, and down 2920.0% year-over-year from 0.07% in Q2 2025.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Tax Rate (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals has reported Tax Rate for 10 years, with the latest figure at 1.94% in Q2 2026.
- On a quarterly basis, Tax Rate fell 2920.0% year-over-year to 1.94% in Q2 2026; TTM through Jun 2026 was 7.03%, a 4965.0% decrease from a year earlier, with the FY2025 full-year figure at 8.1%, up 4239.0% from the prior year.
- Tax Rate was 1.94% for Q2 2026 at Amneal Pharmaceuticals, down from 2.71% in the prior quarter.
- The five-year high for Tax Rate was 447.16% in Q3 2025, with the low at 35.4% in Q4 2024.
- Average Tax Rate over 5 years is 42.42%, with a median of 6.48% recorded in 2025.
- The sharpest annual moves came in 2023 and 2025: Tax Rate sank 22016 bps in 2023, then soared 42339 bps in 2025.
- Over 5 years, Tax Rate stood at 23.51% in 2022, then tumbled by 150 bps to 11.84% in 2023, then plunged by 199 bps to 35.4% in 2024, then jumped by 129 bps to 10.25% in 2025, then plunged by 81 bps to 1.94% in 2026.
- The last three Tax Rate figures came in at 1.94% (Q2 2026), 2.71% (Q1 2026), and 10.25% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -26.59% |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -85.63% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 21.32% |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 1.94% |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 25.29% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 0.09% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 33.43% |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 21.26% |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 2.08% |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94% |
| Mar 31, 2026 | 2.71% |
| Dec 31, 2025 | 10.25% |
| Sep 30, 2025 | 447.16% |
| Jun 30, 2025 | 31.14% |
| Mar 31, 2025 | 34.33% |
| Dec 31, 2024 | -35.40% |
| Sep 30, 2024 | 23.77% |
| Jun 30, 2024 | 17.73% |
| Mar 31, 2024 | -8.15% |
| Dec 31, 2023 | -11.84% |
| Sep 30, 2023 | -9.15% |
| Jun 30, 2023 | -0.08% |
| Mar 31, 2023 | -7.43% |
| Dec 31, 2022 | 23.51% |
| Sep 30, 2022 | 211.01% |
| Jun 30, 2022 | -3.18% |
| Mar 31, 2022 | 35.28% |
| Dec 31, 2021 | -25.12% |
| Sep 30, 2021 | -198.19% |